Safety of insulin analogs during pregnancy: a meta-analysis
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Objective The objective of this study was to assess the safety of four insulin analogs (aspart, lispro, glargine, and detemir) for the treatment of diabetes in pregnancy.Methods We searched Embase, Pubmed, and the Cochrane Central Register for Controlled Trials database through May 31, 2014. All articles were reviewed by two independent researchers, and if a discrepancy was noted, a third researcher was consulted. Results data were summarized by RevMan 5.2 software.Results Our search resulted in the retrieval and screening of 3519 studies. Of those, 24 studies met the eligibility criteria; the studies reported on a total of 3734 women with pre-gestational or gestational diabetes during pregnancy. The use of lispro was associated with lower rates of neonatal jaundice (RR = 0.63) and severe maternal hypoglycemia (RR = 0.33) than regular insulin. Lispro use was also associated with higher birth weight (WMD = 116.44) and an increased incidence of large for gestational age (LGA) births (RR = 1.42) compared with regular insulin. Rates of cesarean section and macrosomia were similar in pregnant women treated with aspart and regular insulin. Birth weights and rates of severe maternal hypoglycemia, respiratory dysfunction syndrome, and neonatal intensive care unit admission were similar after pregnant women were treated with glargine and NPH insulin. Rates of LGA, macrosomia, and neonatal hypoglycemia were similar after pregnant women were treated with detemir and NPH insulin.Conclusions Aspart, glargine, and detemir are safe treatment options for diabetes during pregnancy; these insulin analogs did not increase complications for the mothers or fetuses in our study. However, lispro was related to higher birth weight and increased rate of LGA in neonates. More high-quality randomized controlled trials are needed to clarify the best treatment options for diabetes during pregnancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, the rapid-acting insulin analogs aspart and lispro have acceptable safety and efficacy profiles in pregnancy.59,60”
From Gestational Diabetes Mellitus (2019) · cites this paper as [59]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739 · cited 3×
“Aspart has a similar affinity for the IGF-1 receptor compared to regular insulin, but lispro has a higher affinity for the IGF-1 receptor [28].”
BackgroundSocioeconomic Disparities in Adverse Birth Outcomes
Blumenshine, P., Egerter, S., Barclay, C. J., Cubbin, C., & Braveman, P. A. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.05.012 · Cited by 688
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
DeSisto, C. L., Kim, S. Y., & Sharma, A. J. (2014) · Preventing Chronic Disease · doi:10.5888/pcd11.130415 · Cited by 577
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561 · cited 2×
“However, glargine is not approved for use in pregnancy by the Food and Drug Administration [32].”
BackgroundI., E., Valk, H. D., B., M., Braak, E. T., & G., V. (2002) · Diabetologia · doi:10.1007/s00125-002-0958-7 · Cited by 279
Hod, M., Damm, P., Kaaja, R., Visser, G. H. A., Dunne, F., Demidova, I., Hansen, A.-S. P., & Mersebach, H. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.08.005 · Cited by 176
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling
Sciacca, L., Cassarino, M. F., Genua, M., Pandini, G., Moli, R. L., Squatrito, S., & Vigneri, R. (2010) · Diabetologia · doi:10.1007/s00125-010-1760-6 · Cited by 152
Research works printed but not linked: 1
- Edson EJ, Bracco OL, Vambergue A et al (2010) Managing diabetes during pregnancy with insulin lispro :a safe alternative to human insulin. Endocr Pract 16:1020–1027 · DOI
Cited by
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Szmuilowicz, E. D., Josefson, J. L., & Metzger, B. E. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.001 · Cited by 364
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
“C, Level 3 (135) for aspart and lispro; Grade D, Consensus for glulisine]”
BackgroundMethodInfluentialPractice Bulletin No. 180: gestational diabetes mellitus.
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002159 · Cited by 324
Gestational Diabetes: Overview with Emphasis on Medical Management
Lende, M., & Rijhsinghani, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249573 · Cited by 240
“Recent experience with aspart has been reassuring, while lispro has been associated with higher birth weight and increased rates of large for gestational age neonates [36].”
BackgroundNakshine, V. S., & Jogdand, S. (2023) · Cureus · doi:10.7759/cureus.47500 · Cited by 192
Muller, D. R. P., Stenvers, D. J., Malekzadeh, A., Holleman, F., Painter, R. C., & Siegelaar, S. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1215356 · Cited by 174
Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
Martis, R., Crowther, C. A., Shepherd, E., Alsweiler, J., Downie, M. R., & Brown, J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012327.pub2 · Cited by 159
Guo, L., Ma, J., Tang, J., Hu, D., Zhang, W., & Zhao, X. Q. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9804708 · Cited by 157
A review of current treatment strategies for gestational diabetes mellitus
Kelley, K., Carroll, D., & Meyer, A. (2015) · Drugs in Context · doi:10.7573/dic.212282 · Cited by 88
Gestationsdiabetes (GDM) (Update 2023)
Kautzky‐Willer, A., Winhofer, Y., Kiss, H., Falcone, V., Berger, A., Lechleitner, M., Weitgasser, R., & Harreiter, J. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02181-9 · Cited by 113
Gestationsdiabetes (GDM) (Update 2019)
Kautzky-Willer, A., Harreiter, J., Winhofer-Stöckl, Y., Bancher-Todesca, D., Berger, A., Repa, A., Lechleitner, M., & Weitgasser, R. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-018-1419-8 · Cited by 73
Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
Martis, R., Brown, J., Alsweiler, J., Downie, M. R., & Crowther, C. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012327 · Cited by 88
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy
Dickens, L. T., & Thomas, C. C. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1147-0 · Cited by 83
Management of Gestational Diabetes Mellitus
Oskovi-Kaplan, Z. A., & Ozgu-Erdinc, A. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_552 · Cited by 78
Maternal Midpregnancy Glucose Levels and Risk of Congenital Heart Disease in Offspring
Priest, J. R., Yang, W., Reaven, G., Knowles, J. W., & Shaw, G. M. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.2831 · Cited by 64
Gestational Diabetes Mellitus:current knowledge and unmet needs
Koning, S. H., Hoogenberg, K., Lutgers, H. L., van den Berg, P. P., & Wolffenbuttel, B. H. R. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12422 · Cited by 61
Pharmacological Management of Gestational Diabetes Mellitus
Mukerji, G., & Feig, D. S. (2017) · Drugs · doi:10.1007/s40265-017-0807-0 · Cited by 41
Kautzky‐Willer, A., Harreiter, J., Bancher‐Todesca, D., Berger, A., Repa, A., Lechleitner, M., & Weitgasser, R. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0941-1 · Cited by 34
Management of type 2 diabetes in pregnancy: a narrative review
Raets, L., Ingelbrecht, A., & Benhalima, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193271 · Cited by 33
Pharmacotherapy for hyperglycemia in pregnancy – The new insulins
Toledano, Y., Hadar, E., & Hod, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.035 · Cited by 32
Pharmacotherapy for gestational diabetes
Patti, A. M., Giglio, R. V., Pafili, K., Rizzo, M., & Papanas, N. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1509955 · Cited by 19
Pharmacological Management of Gestational Diabetes Mellitus
Bergel, R., Hadar, E., Toledano, Y., & Hod, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0802-y · Cited by 19
Different Gestational Diabetes Phenotypes: Which Insulin Regimen Fits Better?
Mecacci, F., Lisi, F., Vannuccini, S., Ottanelli, S., Rambaldi, M. P., Serena, C., Simeone, S., & Petraglia, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.630903 · Cited by 17
Polsky, S., GIORDANO, D. A., Voelmle, M. K., Garcetti, R., & Garg, S. K. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1159910 · Cited by 16
Effect of maternal pregestational diabetes mellitus on congenital heart diseases
Chen, Z., Mao, S., Guo, L., Qin, J., Yang, L., & Liu, Y. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-022-00582-w · Cited by 16
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · BMC Medicine · doi:10.1186/s12916-023-02758-1 · Cited by 15
Wang, J., Chen, K., Jin, X., Li, X., An, P., Yang, N., Chen, Y., Fang, Y., & Mu, Y. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s188293 · Cited by 13
Self-citationGestational Diabetes and Type 2 Diabetes During Pregnancy
Mukerji, G., Bacon, S., & Feig, D. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00022-2 · Cited by 13
The care of pregestational and gestational diabetes and drug metabolism considerations
Hedrington, M. S., & Davis, S. N. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1372423 · Cited by 13
Chaves, C., Cunha, F., Martinho, M., Garrido, S., Silva-Vieira, M., Estevinho, C., Melo, A., Figueiredo, O., Morgado, A., Almeida, M. C., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01665-8 · Cited by 12
Glucose Targets and Insulin Choice in Pregnancy: What Has Changed in the Last Decade?
Bacon, S., & Feig, D. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1054-9 · Cited by 11
Li, F., Liu, L., Hu, Y., Marx, C. M., & Liu, W. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-022-01438-z · Cited by 11
Chawla, R., Mukherjee, J. J., Chawla, M. S., Kanungo, A. K., Shunmugavelu, M., & Das, A. K. (2021) · Medical Sciences · doi:10.3390/medsci9020038 · Cited by 10
Controversies in Gestational Diabetes
Zera, C., & Seely, E. W. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.2.102 · Cited by 10
Incidence of maternal and fetal outcomes in women with gestational diabetes.
Lajili, O., Htira, Y., Temessek, A., Hedfi, I., Amara, S. B., & Mami, F. B. (2022) · PubMed Central · Cited by 10
Insulin Therapy and Diabetic Pregnancy
Napoli, A. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001095 · Cited by 9
Basal insulin analogs versus Neutral Protamine Hagedorn for type 2 diabetics
Fishel Bartal, M., Ward, C., Refuerzo, J. S., Ashimi, S. S., Joycelyn, C. A., Chen, H.-Y., Chauhan, S. P., & Sibai, B. M. (2020) · American Journal of Perinatology · doi:10.1055/s-0039-1694733 · Cited by 8
Wang, J., Ji, X., Liu, T., & Zhao, N. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00925-7 · Cited by 8
Self-citationSaboo, B., Chandalia, H. B., Ghosh, S. K., Kesavadev, J., Kochar, I. S., Prasannakumar, K. M., Sarda, A., Bantwal, G., Mehrotra, R., & Rai, M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230310150905 · Cited by 7
Effect of Different Insulin Therapies on Obstetric-Fetal Outcomes
López‐Tinoco, C., Jiménez-Blázquez, J. L., Larrán-Escandón, L., Roca-Rodríguez, M. D. M., Bugatto, F., & Aguilar‐Diosdado, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-54164-4 · Cited by 7
Insulin and its analogues– what are they for? (pros and cons)
Güney, Z. (2019) · Trends in Diabetes and Metabolism · doi:10.15761/tdm.1000113 · Cited by 7
Pharmacological therapy in gestational diabetes – a comparison between insulin and oral therapy
Shmuel, E., Krispin, E., Toledano, Y., Chen, R., Wiznitzer, A., & Hadar, E. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1875208 · Cited by 7
Gravidität bei vorbestehendem Diabetes (Update 2019)
Kautzky‐Willer, A., Harreiter, J., Winhofer-Stöckl, Y., Weitgasser, R., & Lechleitner, M. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1456-y · Cited by 6
Allergic reactions to insulin detemir in women with gestational diabetes mellitus.
Morton, A., & Laurie, J. G. (2016) · PubMed · Cited by 6
Harreiter, J., & Kautzky‐Willer, A. (2016) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-016-0078-9 · Cited by 6
Kautzky‐Willer, A., Harreiter, J., Weitgasser, R., & Lechleitner, M. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0943-z · Cited by 6
Caring for pregnant women whose diabetes antedates pregnancy: is there room for improvement?
Sacks, D. A., & Feig, D. S. (2018) · Diabetologia · doi:10.1007/s00125-018-4565-7 · Cited by 6
Silva, K., Valero, P., Espinoza, F., Rivas, J. C., Sauceda-Acosta, D., & Sobrevía, L. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_803 · Cited by 5
Gestational diabetes mellitus management: diet and lifestyle
Allehdan, S., Basha, A. S., & Tayyem, R. (2020) · Nutrition & Food Science · doi:10.1108/nfs-03-2020-0095 · Cited by 5
Gestational Diabetes: From Mechanism to Therapy – A Short Review
Cursaru, R., Bratu, A., Radulian, G., Pavelescu, M. L., Rusu, E., Cirstoiu, F. C., & Cursaru, A. (2024) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2024.127.6.10 · Cited by 4
Gravidität bei vorbestehendem Diabetes (Update 2023)
Kautzky‐Willer, A., Winhofer, Y., Weitgasser, R., Lechleitner, M., & Harreiter, J. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02188-2 · Cited by 4
Systematic Literature Review of Basal Bolus Insulin Analogue Therapy during Pregnancy
Henderson, C. E. (2015) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2015.03.00079 · Cited by 3
Insulin therapy in diabetic kidney disease
Liu, Y., Zhao, C., Xiong, X., Yang, M., & Sun, L. (2021) · Diabetic Nephropathy · doi:10.2478/dine-2022-0006 · Cited by 2
Zhang, W., Ren, L., Du, J., Sun, R., Zhao, W., Song, X., Jiang, S., Wang, Z., & Wang, W. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1737337 · Cited by 2
Type 1 diabetes and pregnancy: An update on glucose monitoring and insulin treatment
Amigó, J., & Corcoy, R. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.06.008 · Cited by 2
Pharmacotherapy of Gestational Diabetes Mellitus: Current Recommendations
Radenković, M., & Jakovljević, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100266 · Cited by 2
Review on pharmacological therapies for management of gestational diabetes
Shabnam, A., & Safia, B. (2023) · International Journal of Pharmaceutical Sciences and Developmental Research · doi:10.17352/ijpsdr.000047 · Cited by 2
Kaczmarek, A., Kaczmarek, W., Krakowiak, M., Gołacki, R., Jabłonowska, M., & Bagiński, K. (2025) · Quality in Sport · doi:10.12775/qs.2025.46.66545 · Cited by 2
Medications for Pregnant Women With Obesity: Special Considerations
Maggio, L. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000584 · Cited by 2
Amigó, J., & Corcoy, R. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.09.005 · Cited by 2
Comparison of Fetal Outcome in Patients of Gestational Diabetes Treated with Met Formin and Insulin
Sajjad, F., Usman, S., Choudhry, A., Baloch, S. A., Aslam, Q. U. A., & Shahid, G. (2022) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v72isuppl-2.3872 · Cited by 1
DIABETES MELLITUS GESTACIONAL: UMA REVISÃO DAS OPÇÕES TERAPÊUTICAS
Costa, P. P. T., Andrade, I. R., Martins, G. C., de Oliveira, M. C., & Novaes, T. M. D. M. (2024) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v10i8.15188 · Cited by 1
Effective Postprandial Glucose Management in Pregnancy with Type 1 Diabetes
Polsky, S. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0143 · Cited by 1
Features of insulin therapy in patients with type 1 diabetes mellitus during pregnancy
Zhuravlyova, L., & Rogachova, T. (2018) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2018.01.078 · Cited by 1
GESTATIONAL DIABETES TREATMENT STRATEGIES
Мищенко, О. И., Марцияш, А. А., Мозес, К. Б., Мозес, В. Г., Рудаева, Е. В., Елгина, С. И., Захаров, И. С., Черных, Н. С., & Сашко, А. А. (2020) · Matʹ i ditâ v Kuzbasse · Cited by 1
Writers, A. M. (2018) · Drugs & Therapy Perspectives · doi:10.1007/s40267-018-0501-7
Bergel, R., Hadar, E., Toledano, Y., & Hod, M. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_23-1 · Cited by 1
Kernaspekte der aktualisierten S3-Leitlinie Gestationsdiabetes
Stupin, J. H. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1297-1
Fall 62: Therapie – 33 Jahre, ♀, DM Typ 2, schwanger, Übergewicht
Kasperk, C. (2018) · Springer eBooks · doi:10.1007/978-3-662-55972-7_62
Martis, R. (2018) · Wintec Research Archive (Waikato Institute of Technology)
Treatment of Gestational Diabetes
Maged, A. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86988
Konservative und medikamentöse Therapie des Gestationsdiabetes mellitus
Kleinwechter, H. J., & Laubner, K. (2019) · Der Diabetologe · doi:10.1007/s11428-019-00543-4
Novosti u liječenju gestacijskog dijabetesa
Hlača, N., & Majanović, S. K. (2019) · Medicina Fluminensis · doi:10.21860/medflum2019_227123
Management of gestational diabetes mellitus to optimize outcomes
Toledano, Y., Hadar, E., & Hod, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817921-5.00019-9
Estupiñán, G. P. F., Cabrera, T. V., & Estrada, J. G. (2020) · Revista Neuropsicologia Latinoamericana · doi:10.5579/rnl.2020.0599
Bergel, R., Hadar, E., Toledano, Y., & Hod, M. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_23
Bergel, R., Hadar, E., Toledano, Y., & Hod, M. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_23-2
Bergel, R., Hadar, E., Toledano, Y., & Hod, M. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_23
ALTUNAY, F. K. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/5786955648
Gestational Diabetes and Type 2 Diabetes during Pregnancy
Bond, R., & Peters, T. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00050-8
Insulin Treatment for Gestational Diabetes Mellitus
Winata, I. G. S., Mahendrata, P., Widia, M. Y. G. W., Setiawan, W. A., & Nathalia, J. (2025) · Indonesian Journal of Obstetrics & Gynecology Science · doi:10.24198/obgynia.v8i3.823
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655484
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655499
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655508
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655511
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655481
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655505
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655496
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655493
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655487
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655490
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655502
Picard, M. (2023) · Serveur des thèses de l'Université de Strasbourg (University of Strasbourg)
Vallières, M.-F. (2023) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/3160
(2026) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2026/15.3.10014
The use of probiotics in the nutrition of patients with gestational diabetes mellitus
Κρίκη, Γ. Ν., & Χριστάκος, Ν. Μ. (2023) · University of Thessaly Institutional Repository (University of Thessaly)
Pellerin, M. (2015) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Toledano, Y., & Hod, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13265-0.00008-2
Metadata
- Authors
- Lv, S., Wang, J., & Xu, Y.
- Affiliations
- Southwest Medical University (CN)
- Corresponding author
- Xu, Yong
- ORCID
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2015-04-09
- Volume
- 292
- Issue
- 4
- Pages
- 749-756
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- OpenAlex
- W2048000124
- Cited by
- 88
- References
- 40
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 19 · 2022: 7 · 2021: 8 · 2020: 6 · 2019: 15 · 2018: 12 · 2017: 3 · 2016: 9 · 2015: 3
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin analogues, diabetes in pregnancy, gestational diabetes mellitus, pregestational diabetes, insulin aspart, insulin lispro, insulin glargine, insulin detemir, neonatal hypoglycemia, neonatal jaundice, birth weight, large for gestational age, macrosomia, cesarean section, neonatal intensive care admission, NPH insulin, regular insulin
- MeSH terms
- Insulin Glargine, Insulin Detemir, Adult, Birth Weight, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Infant, Newborn, Infant, Newborn, Diseases, Insulin, Pregnancy, Pregnancy in Diabetics, Pregnancy Outcome, Diabetes, Gestational, Insulin Aspart, Insulin Lispro
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.